TY - JOUR
T1 - In vivo adenovirus-mediated endothelial nitric oxide synthase gene transfer ameliorates lung allograft ischemia-reperfusion injury
AU - Suda, Takashi
AU - Mora, Bassem N.
AU - D'Ovidio, Franco
AU - Cooper, Jonas A.
AU - Hiratsuka, Masafumi
AU - Zhang, Wanjiang
AU - Mohanakumar, T.
AU - Patterson, G. Alexander
N1 - Funding Information:
Supported by National Institutes of Health grant 1 R01 HL41281.
PY - 2000
Y1 - 2000
N2 - Objective: Nitric oxide regulates vascular tone, inhibits platelet aggregation, and inhibits leukocyte adhesion, all of which are important modulators of ischemia-reperfusion injury. This study aimed to determine the effects of endothelial constitutive nitric oxide synthase gene transfer on ischemia-reperfusion injury in a rat lung transplant model. Methods: In group I, donor animals were injected intravenously with 5 x 109 pfu of adenovirus- encoding endothelial constitutive nitric oxide synthase. Groups II and III served as controls, whereby donor animals were injected with either 5 x 109 pfu of adenovirus encoding β-galactosidase or saline solution, respectively. Twenty-four hours after injection, left lungs were harvested and preserved for 18 hours at 4°C, then implanted into isogeneic recipients, which were put to death 24 hours later. Recombinant endothelial constitutive nitric oxide synthase gene expression was evaluated by Western blotting and immunohistochemistry. Lung grafts were assessed by measuring arterial oxygenation, myeloperoxidase activity, and wet/dry weight ratios. Results: Western blotting confirmed the overexpression of endothelial constitutive nitric oxide synthase in lungs so transfected compared with controls. Twenty- four hours after reperfusion, mean arterial oxygenation was significantly improved in group I compared with group H and HI controls (189.4 ± 47.1 mm Hg vs 71.7 ± 8.9 mm Hg and 67.8 ± 12.2 mm Hg, P = .02, P = .01, respectively). Myeloperoxidase activity, a reflection of tissue neutrophil sequestration, was also significantly reduced in group I compared with groups H and III (0.136 ± 0.038 ΔOD/mg/min vs 0.587 ± 0.077 and 0.489 ± 0.126 ΔOD/mg/min, P = .001, P = .01, respectively). Conclusion: Adenovirus- mediated gene transfer with endothelial constitutive nitric oxide synthase ameliorates ischemia-reperfusion injury as manifested by significantly improved oxygenation and decreased neutrophil sequestration in transplanted lung isografts. Endothelial constitutive nitric oxide synthase gene transfer may reduce acute lung dysfunction after lung transplantation.
AB - Objective: Nitric oxide regulates vascular tone, inhibits platelet aggregation, and inhibits leukocyte adhesion, all of which are important modulators of ischemia-reperfusion injury. This study aimed to determine the effects of endothelial constitutive nitric oxide synthase gene transfer on ischemia-reperfusion injury in a rat lung transplant model. Methods: In group I, donor animals were injected intravenously with 5 x 109 pfu of adenovirus- encoding endothelial constitutive nitric oxide synthase. Groups II and III served as controls, whereby donor animals were injected with either 5 x 109 pfu of adenovirus encoding β-galactosidase or saline solution, respectively. Twenty-four hours after injection, left lungs were harvested and preserved for 18 hours at 4°C, then implanted into isogeneic recipients, which were put to death 24 hours later. Recombinant endothelial constitutive nitric oxide synthase gene expression was evaluated by Western blotting and immunohistochemistry. Lung grafts were assessed by measuring arterial oxygenation, myeloperoxidase activity, and wet/dry weight ratios. Results: Western blotting confirmed the overexpression of endothelial constitutive nitric oxide synthase in lungs so transfected compared with controls. Twenty- four hours after reperfusion, mean arterial oxygenation was significantly improved in group I compared with group H and HI controls (189.4 ± 47.1 mm Hg vs 71.7 ± 8.9 mm Hg and 67.8 ± 12.2 mm Hg, P = .02, P = .01, respectively). Myeloperoxidase activity, a reflection of tissue neutrophil sequestration, was also significantly reduced in group I compared with groups H and III (0.136 ± 0.038 ΔOD/mg/min vs 0.587 ± 0.077 and 0.489 ± 0.126 ΔOD/mg/min, P = .001, P = .01, respectively). Conclusion: Adenovirus- mediated gene transfer with endothelial constitutive nitric oxide synthase ameliorates ischemia-reperfusion injury as manifested by significantly improved oxygenation and decreased neutrophil sequestration in transplanted lung isografts. Endothelial constitutive nitric oxide synthase gene transfer may reduce acute lung dysfunction after lung transplantation.
UR - http://www.scopus.com/inward/record.url?scp=0033951261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033951261&partnerID=8YFLogxK
U2 - 10.1016/S0022-5223(00)70185-1
DO - 10.1016/S0022-5223(00)70185-1
M3 - Article
C2 - 10649205
AN - SCOPUS:0033951261
SN - 0022-5223
VL - 119
SP - 297
EP - 304
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 2
ER -